Pfizer COVID vaccine clears Japan panel for use with young children




  • In Health
  • 2022-10-05 10:26:44Z
  • By Reuters
 

TOKYO (Reuters) -A Japanese health ministry panel on Wednesday recommended approving Pfizer Inc's COVID-19 vaccine for children as young as six months old.

Japan in January expanded use of the vaccine to those as young as five years old. Last month, health authorities started to dispensing Pfizer and Moderna Inc booster shots that target the Omicron variant of the virus.

The panel also recommended approval of a version of the Pfizer vaccine that protects against the BA.4 and BA.5 subvariants of Omicron. Moderna said earlier on Wednesday it was seeking Japanese approval of its own subvariant shot.

(Reporting by Rocky Swift and Kantaro Komiya, Editing by Louise Heavens)

COMMENTS

More Related News

U.S. FDA grants priority review to Pfizer
U.S. FDA grants priority review to Pfizer's RSV vaccine
  • US
  • 2022-12-07 11:52:49Z

It could become the first approved RSV vaccine in the U.S. for older adults who are at risk of the lung disease. Pfizer's application to the FDA is...

Mercedes opens its first EV-only dealership in the world in Japan
Mercedes opens its first EV-only dealership in the world in Japan
  • US
  • 2022-12-06 09:28:47Z

Mercedes-Benz's first dealership in the world dedicated to its all-electric Mercedes-EQ brand opened in Yokohama, south of the Japanese capital on Tuesday...

Asian Stocks Mixed With Focus on Fed, China Covid: Markets Wrap
Asian Stocks Mixed With Focus on Fed, China Covid: Markets Wrap

(Bloomberg) -- Asian stocks were mixed as investors weighed unexpectedly strong US services data and China's accelerated moves toward exiting its Covid-Zero ...

Japan
Japan's Households Spend More Despite Accelerating Inflation

(Bloomberg) -- Japan's households boosted spending in October for a second straight month despite accelerating inflation and falling real wages, marking a...

Leave a Comment

Your email address will not be published. Required fields are marked with *

Cancel reply

Comments

Top News: Health